Sirtuin 2 enhances dopaminergic differentiation via the AKT/GSK-3β/β-catenin pathway.

Szegő, Éva M

Sirtuin 2 enhances dopaminergic differentiation via the AKT/GSK-3β/β-catenin pathway. [electronic resource] - Neurobiology of aging 08 2017 - 7-16 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1558-1497

10.1016/j.neurobiolaging.2017.04.001 doi


Animals
Benzamides--pharmacology
Cell Differentiation--genetics
Cells, Cultured
Dopaminergic Neurons--cytology
Glycogen Synthase Kinase 3 beta--metabolism
Mesencephalon--cytology
Mice, Knockout
Parkinson Disease--genetics
Phosphorylation--genetics
Proto-Oncogene Proteins c-akt--metabolism
Rats, Wistar
Signal Transduction--genetics
Sirtuin 2--antagonists & inhibitors
Substantia Nigra--cytology
Sulfonamides--pharmacology
beta Catenin--metabolism